Janux Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Janux Therapeutics, Inc. (JANX)

15.13 +1.86 (+14.02%) USD | NASDAQ | Jan 22, 16:00

15.04 -0.09 (-0.59%) After-Hours: 19:50

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for JANX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Ionis Pharmaceuticals, Inc.	Upgrade
MannKind Corp.	Upgrade
Madrigal Pharmaceuticals, Inc.	Upgrade
Editas Medicine, Inc.	Upgrade